My Healthy Waist, profile picture

My Healthy Waist

22 Slideshow
Sort by
Update on Management of Atherogenic Dyslipidemia of Insulin Resistance, Obesity, and Type 2 Diabetes: Beyond LDL Cholesterol
byMy Healthy Waist
 
Global Sugar-Sweetened Beverage Sale Barometer
byMy Healthy Waist
 
Targeting abdominal obesity in diabetology: What can we do about it?
byMy Healthy Waist
 
Lifestyle modification in the prevention of type 2 diabetes: The experience with the Diabetes Prevention Program and Look AHEAD studies
byMy Healthy Waist
 
Hypertrophic obesity is associated with type 2 diabetes and impaired adipogenesis
byMy Healthy Waist
 
Clinical Management of CVD Risk in Abdominal Obesity and Type 2 Diabetes Targeting Blood Pressure
byMy Healthy Waist
 
Global dimensions of sugary beverages in programmatic and policy solutions.
byMy Healthy Waist
 
Physical Activity in the Management of Abdominal Obesity
byMy Healthy Waist
 
Ectopic Fat: An Important Feature of Intra-Abdominal Obesity in Type 2 Diabetes
byMy Healthy Waist
 
Managing cardiometabolic risk
byMy Healthy Waist
 
Fatty acid metabolism in humans
byMy Healthy Waist
 
Metabolic syndrome and adipose tissue
byMy Healthy Waist
 
Role of the dysregulated endocannabinoid system in determining cardiometabolic risk.
byMy Healthy Waist
 
Abdominal obesity, intra-abdominal adiposity and related cardiometabolic risk: part I
byMy Healthy Waist
 
The concept of cardiometabolic risk
byMy Healthy Waist